HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 45 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,653,648 | -6.7% | 508,198 | +0.2% | 0.01% | 0.0% |
| Q2 2023 | $17,853,083 | +33.1% | 507,334 | +23.5% | 0.01% | +20.0% |
| Q1 2023 | $13,417,093 | -28.4% | 410,937 | +20.8% | 0.01% | -28.6% |
| Q4 2022 | $18,739,675 | +1.8% | 340,103 | -18.1% | 0.01% | 0.0% |
| Q3 2022 | $18,400,000 | -2.5% | 415,451 | +7.4% | 0.01% | 0.0% |
| Q2 2022 | $18,870,000 | -0.5% | 386,912 | -0.7% | 0.01% | +16.7% |
| Q1 2022 | $18,962,000 | -20.6% | 389,760 | -30.4% | 0.01% | -14.3% |
| Q4 2021 | $23,873,000 | -6.7% | 559,868 | -16.2% | 0.01% | 0.0% |
| Q3 2021 | $25,596,000 | +34.0% | 667,784 | -1.3% | 0.01% | +16.7% |
| Q2 2021 | $19,101,000 | -4.4% | 676,620 | +11.9% | 0.01% | 0.0% |
| Q1 2021 | $19,985,000 | +7.6% | 604,865 | +17.8% | 0.01% | 0.0% |
| Q4 2020 | $18,566,000 | +66.1% | 513,570 | +55.8% | 0.01% | +50.0% |
| Q3 2020 | $11,176,000 | – | 329,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |